Konoshima Chemical (4026) Fundamentals 2026 — P/E 7.6x, Revenue Analysis | SniperIQ
Konoshima Chemical (4026) is a JP-listed Industrials company in Construction with a market capitalization of ¥14.1B, trading at ¥1555.00 on the JPX. This SniperIQ fundamentals page covers Konoshima Chemical's valuation (P/E 7.6x, P/B 1.0x), profitability (net margin 6.6%), revenue (¥28.0B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Konoshima Chemical's market cap?
Konoshima Chemical (4026) has a market capitalization of approximately ¥14.1B, trading at ¥1555.00 on the JPX. Market cap moves with the live share price.
What is Konoshima Chemical's P/E ratio?
Konoshima Chemical's trailing twelve-month P/E ratio is 7.6x, with a price-to-book (P/B) of 1.0x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Konoshima Chemical?
Konoshima Chemical runs a net profit margin of 6.6%, a gross margin of 28.9%, and an operating margin of 9.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Konoshima Chemical generate?
Konoshima Chemical reported revenue of ¥28.0B for fiscal year 2025, with net income of ¥1.9B and earnings per share (EPS) of 203.74. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Konoshima Chemical pay a dividend?
Konoshima Chemical offers a trailing dividend yield of about 3.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Konoshima Chemical financially healthy?
Konoshima Chemical carries a debt-to-equity ratio of 0.62x and a current ratio of 0.96x, with a market beta of 0.92. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Konoshima Chemical a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Konoshima Chemical (4026) the key facts are: market cap ¥14.1B, P/E 7.6x, revenue ¥28.0B, 52-week range 1261-2148. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Konoshima Chemical's full fundamentals live
Get Konoshima Chemical's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.